<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>453</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15240887</PubmedId>
            <Abstract>Prion diseases are associated with the conversion of the alpha-helix rich prion protein (PrPC) into a beta-structure-rich insoluble conformer (PrPSc) that is thought to be infectious. The mechanism for the PrPC--&gt;PrPSc conversion and its relationship with the pathological effects of prion diseases are poorly understood, partly because of our limited knowledge of the structure of PrPSc. In particular, the way in which mutations in the PRNP gene yield variants that confer different susceptibilities to disease needs to be clarified. We report here the 2.5-A-resolution crystal structures of three scrapie-susceptibility ovine PrP variants complexed with an antibody that binds to PrPC and to PrPSc; they identify two important features of the PrPC--&gt;PrPSc conversion. First, the epitope of the antibody mainly consists of the last two turns of ovine PrP second alpha-helix. We show that this is a structural invariant in the PrPC--&gt;PrPSc conversion; taken together with biochemical data, this leads to a model of the conformational change in which the two PrPC C-terminal alpha-helices are conserved in PrPSc, whereas secondary structure changes are located in the N-terminal alpha-helix. Second, comparison of the structures of scrapie-sensitivity variants defines local changes in distant parts of the protein that account for the observed differences of PrPC stability, resistant variants being destabilized compared with sensitive ones. Additive contributions of these sensitivity-modulating mutations to resistance suggest a possible causal relationship between scrapie resistance and lowered stability of the PrP protein.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>10254-9</ArticlePages>
            <ArticleTitle>Insight into the PrPC--&gt;PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Eghiaian</LastName>
                    <ForeName>Frédéric</ForeName>
                </Author>
                <Author>
                    <LastName>Grosclaude</LastName>
                    <ForeName>Jeanne</ForeName>
                </Author>
                <Author>
                    <LastName>Lesceu</LastName>
                    <ForeName>Stéphanie</ForeName>
                </Author>
                <Author>
                    <LastName>Debey</LastName>
                    <ForeName>Pascale</ForeName>
                </Author>
                <Author>
                    <LastName>Doublet</LastName>
                    <ForeName>Bénédicte</ForeName>
                </Author>
                <Author>
                    <LastName>Tréguer</LastName>
                    <ForeName>Eric</ForeName>
                </Author>
                <Author>
                    <LastName>Rezaei</LastName>
                    <ForeName>Human</ForeName>
                </Author>
                <Author>
                    <LastName>Knossow</LastName>
                    <ForeName>Marcel</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratoire d'Enzymologie et de Biochimie Structurales, Centre National de la Recherche Scientifique, 91198 Gif sur Yvette, France.</Affiliations>
            <ArticleChemicalList>Epitopes;PrPC Proteins;PrPSc Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibody Specificity; Antigen-Antibody Reactions; Crystallography; Epitopes(immunology); Mice; Mutation; PrPC Proteins(chemistry; genetics; immunology); PrPSc Proteins(chemistry; genetics; immunology); Protein Structure, Secondary; Protein Structure, Tertiary; Scrapie(immunology); Sheep</ArticleMeshHeadingsList>
            <Journal>
                <Volume>101</Volume>
                <Issue>28</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of VRQ14 Fab on ovine PrP</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KQHTVTTTTKGE</LinearSequence>
                        <StartingPosition>188</StartingPosition>
                        <EndingPosition>199</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23907.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9940</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3 and PDB 1TPX, 1TQC and 1TCB</LocationOfData>
                <EpitopeId>32990</EpitopeId>
                <ReferenceStartingPosition>188</ReferenceStartingPosition>
                <ReferenceEndingPosition>199</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3, Table 1 and PDB 1TQC</LocationOfData>
                        <BCellId>1376700</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.8</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of VRQ14 Fab on the C-terminal domain of ovine PrP variant ARR was determined from the crystal structure of the complex, solved by molecular replacement. Variant ARR contains residues A136, R154, R171 and is associated with resistance to scrapie.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>OvPrP C-terminal domain ARR variant</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDRYSNQNNFVHDCVNITVKQHTVTTTTKGENFTETDIKIMERVVEQMCITQYQRESQAY</LinearSequence>
                                        <StartingPosition>127</StartingPosition>
                                        <EndingPosition>228</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23907.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9940</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1TQC</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>C</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>VRQ14 epitope is conserved in three isoforms of prion protein: ARQ  (A136-R154-Q171 polymorphisms, pathogenic medium scrapie susceptible isoform) [PDB: 1TPX], ARR (A136-R154-R171 normal scrapie resistant isoform) [PDB: 1TQC], and VRQ (V136-R154-Q171 polymorphisms, pathogenic high scrapie susceptible isoform) [PDB: 1TQB].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: K188, Q189, H190, T191, V192, T193, T194, T195, T196, K197, G198, E199</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; C: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: G127, L128, Y152, N156, Y158, R159, I185, K188, Q189, T191, V192, T193, T194, T195, T196, K197, G198, E199, N200</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: T30, N31, Y32, G33, N35, W50, N52, F53, T54, G95, T96; C: D29B, K30C, Y32, N34, R46, Y49, L50, R53, G91, S92, Q96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>972.7</ContactAreaForAntigen>
                                <ContactAreaForAntibody>935.9</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3 and Supporting Information Figure 6</LocationOfData>
                        <BCellId>1376705</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific mAb VRQ14 recognized both infected and uninfected brain homogenates from sheep, mouse, hamster and macaque. The mAb did not react with Prnp(0/0) mouse brain homogenates, which lack Prp.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Scrapie-infected and uninfected brain homogenates</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <DerivativeOfOrganism>
                                        <SubType>Anatomical Entity</SubType>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </DerivativeOfOrganism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Supporting Information Figure 6</LocationOfData>
                        <BCellId>1376707</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific mAb VRQ14 recognized both infected and uninfected brain homogenates from sheep, mouse, hamster and macaque.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Scrapie-infected and uninfected brain homogenates</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <DerivativeOfOrganism>
                                        <SubType>Anatomical Entity</SubType>
                                        <SourceOrganismId>9539</SourceOrganismId>
                                    </DerivativeOfOrganism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3, Table 1 and PDB 1TPX</LocationOfData>
                        <BCellId>2213</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.56</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of VRQ14 Fab on the C-terminal domain of ovine PrP variant ARQ was determined from the crystal structure of the complex, solved by molecular replacement. Variant ARQ contains residues A136, R154, Q171 and is associated with medium susceptibility to scrapie.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>OvPrP C-terminal domain ARQ variant</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDRYSNQNNFVHDCVNITVKQHTVTTTTKGENFTETDIKIMERVVEQMCITQYQRESQAYYQRGAS</LinearSequence>
                                        <StartingPosition>114</StartingPosition>
                                        <EndingPosition>234</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23907.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9940</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1TPX</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>C</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>VRQ14 epitope is conserved in three isoforms of prion protein: ARQ  (A136-R154-Q171 polymorphisms, pathogenic medium scrapie susceptible isoform) [PDB: 1TPX], ARR (A136-R154-R171 normal scrapie resistant isoform) [PDB: 1TQC], and VRQ (V136-R154-Q171 polymorphisms, pathogenic high scrapie susceptible isoform) [PDB: 1TQB].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: K188, Q189, H190, T191, V192, T193, T194, T195, T196, K197, G198, E199</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; C: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: G127, L128, N156, Y158, R159, I185, K188, Q189, T191, V192, T193, T194, T195, T196, K197, G198, E199, N200</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: T30, N31, Y32, G33, N35, W50, N52, F53, T54, G95, T96; C: D29B, K30C, Y32, N34, R46, Y49, L50, R53, G91, S92, Q96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>980.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>923.2</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3 and Supporting Information Figures 5 and 6</LocationOfData>
                        <BCellId>1376702</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific mAb VRQ14 recognized both infected and uninfected sheep brain homogenates in ELISA and immunoblot indicating that  VRQ14 interacted with cellular PrP&lt;sup&gt;C&lt;/sup&gt; and pathological PrP&lt;sup&gt;Sc&lt;/sup&gt; forms. Similar results were observed with the VRQ14 Fab fragment in competition ELISA. The mAb also interacted with normal or infected brain homogenates from mouse, hamster and macaque.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>scrapie-infected and uninfected sheep brain homogenates</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Derivative of Source Organism</EpitopeRelation>
                                <Object>
                                    <DerivativeOfOrganism>
                                        <SubType>Anatomical Entity</SubType>
                                        <SourceOrganismId>9940</SourceOrganismId>
                                    </DerivativeOfOrganism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Supporting Information Figure 6</LocationOfData>
                        <BCellId>1376706</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific mAb VRQ14 recognized both infected and uninfected brain homogenates from sheep, mouse, hamster and macaque.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Scrapie-infected and uninfected brain homogenates</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <DerivativeOfOrganism>
                                        <SubType>Anatomical Entity</SubType>
                                        <SourceOrganismId>10026</SourceOrganismId>
                                    </DerivativeOfOrganism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3, Table 1 and PDB 1TQB</LocationOfData>
                        <BCellId>1376701</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000645</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P23907.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9940</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ovine Prp variant VRQ</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The VRQ14 hybridoma was produced by immunization of Prnp (0/0) mice with recombinant ovine PrP variant VRQ, which contains the residues V136, R154, Q171 that confers high scrapie susceptibility.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.55</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of VRQ14 Fab on the C-terminal domain of ovine PrP variant VRQ was determined from the crystal structure of the complex. Variant VRQ contains residues V136, R154, Q171 and is associated with high susceptibility to scrapie.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>VRQ14</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>VRQ14</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1TQB_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1TQB_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>OvPrP C-terminal domain VRQ variant</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDRYSNQNNFVHDCVNITVKQHTVTTTTKGENFTETDIKIMERVVEQMCITQYQRESQAY</LinearSequence>
                                        <StartingPosition>127</StartingPosition>
                                        <EndingPosition>228</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23907.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9940</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1TQB</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>C</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>VRQ14 epitope is conserved in three isoforms of prion protein: ARQ  (A136-R154-Q171 polymorphisms, pathogenic high scrapie susceptible isoform) [PDB: 1TPX], ARR (A136-R154-R171 normal scrapie resistant isoform) [PDB: 1TQC], and VRQ (V136-R154-Q171 polymorphisms, pathogenic medium scrapie susceptible isoform) [PDB: 1TQB].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: K188, Q189, H190, T191, V192, T193, T194, T195, T196, K197, G198, E199</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: ; C: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: G127, L128, N156, Y158, R159, I185, K188, Q189, T191, V192, T193, T194, T195, T196, K197, G198, E199, N200</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>B: T30, N31, Y32, G33, N35, W50, N52, F53, T54, G95, T96; C: D29B, K30C, Y32, N34, R46, Y49, L50, R53, G91, S92, Q96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>978.2</ContactAreaForAntigen>
                                <ContactAreaForAntibody>924.8</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

